In consultation: Guidance and quality standards

Skip to filters Skip to results

Showing 1 to 3 of 3

Sort by

Type: GuidanceRemove Type: Guidance filter
Type: NICE adviceRemove Type: NICE advice filter
Type: Quality standardRemove Type: Quality standard filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Highly specialised technologies guidanceRemove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Antimicrobial prescribing guidelinesRemove Guidance programme: Antimicrobial prescribing guidelines filter
Guidance programme: Clinical guidelinesRemove Guidance programme: Clinical guidelines filter
Guidance programme: Diagnostics guidanceRemove Guidance programme: Diagnostics guidance filter
Guidance programme: Medicines practice guidelinesRemove Guidance programme: Medicines practice guidelines filter
Guidance programme: Public health guidelinesRemove Guidance programme: Public health guidelines filter
Guidance programme: Safe staffing guidelinesRemove Guidance programme: Safe staffing guidelines filter
Guidance programme: Social care guidelinesRemove Guidance programme: Social care guidelines filter

Guidance and quality standards in consultation
Title	Consultation	Type	Consultation end date
Elacestrant for treating oestrogen receptor-positive, HER2-negative advanced breast cancer with an ESR1 mutation after at least 1 endocrine treatment [ID6225]	Draft guidance	Technology appraisal guidance	22 October 2024
Cabotegravir for preventing HIV-1 in adults and young people [ID6255]	Draft guidance	Technology appraisal guidance	17 October 2024
Fosdenopterin for treating molybdenum cofactor deficiency type A [ID6264]	Evaluation consultation	Highly specialised technology	10 October 2024

Results per page

10
25
50
All